Il rapporto
Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo
10 report e oltre
Abcuro Raises $66M Series D for Inclusion Body Myositis Trial
Abcuro raised a $66 million Series D led by New Leaf Venture Partners to fund a new potentially registrational study of ulviprubart in inclusion body myositis.
Vibrant Therapeutics Raises $61M Series B | Logic-Gated Cancer Immunotherapy
Clinical-stage biotech Vibrant Therapeutics secures $61 million Series B for tumor microenvironment-activated immunotherapies.
BioNTech raises $325M Follow-on Offering at $45B valuation
BioNTech raises $325M in Follow-on Offering at $45B valuation. Immunotherapy and mRNA vaccines...
Torl Biotherapeutics raises $96M Series C at $500M valuation
Torl Biotherapeutics raises $96M in Series C at $500M valuation. Antibody-based immunotherapies for cancer patients...
BioNTech Headquarters - Office Location & Address
Discover BioNTech's headquarters at 40 Erie St, Cambridge, MA 02139. Immunotherapy developer. Learn about the office facilities and work environment.
BioNTech SE Headquarters - Office Location & Address
Discover BioNTech SE's headquarters at An der Goldgrube 12, Mainz, 55131. Immunotherapy and vaccine developer. Learn about the office facilities and work environment.
Atara Biotherapeutics Headquarters - Office Location & Address
Discover Atara Biotherapeutics's headquarters at 611 Gateway Blvd, South San Francisco, CA 94080. T-cell immunotherapy developer. Learn about the office facilities and work environment.
Abcuro Raises $200M Series C to Transform Biotech
Abcuro has secured $200M Series C in funding to accelerate growth and innovation in the biotech sector. Precision oncology company discovering and developing novel cancer immunotherapies targeting tumor microenvironments...
Torl Biotherapeutics Raises $96M in Series C
Torl Biotherapeutics, a Biotech company based in Los Angeles, CA, has raised $96M in Series C at a $500M valuation led by Cormorant Asset Management, BVF Partners.
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.